Management of Roche Immuno-analysis portfolio
o Management of 2 PM and 1 annual trainee
o Position the whole Roche Immuno-analysis portfolio in 3 differentiating brands
o Creation of a global strategy and global communication (biochemists and clinicians)
o Launch of a new statement Enhance clinicians and biochemists dialog
o Creation of 3 Advisory Boards and management of several KOL networks
o Important relationship with Roche International
Growth > 20%
Strong increase of each brand awareness
Management of the Near Patient Testing portfolio
o Management of 2 PM and 1 annual trainee
o Launch of TéléBiologie brand
Strong awareness of TéléBiologie
Roche Diagnostics
- Cardiac Markers Senior PM
Meylan2004 - 2007Responsible for the biochemists and clinicians communication
o Definition of qualitative and quantitative objectives, Business Plan working out
o Strategy and campaigns working out and follow up
Planning for innovative actions : physician call and e-detailing
o Creation of a Cardiac Advisory Board
RUEIL MALMAISON 1999 - 2002TAREG PM (antihypertensive - 53 M€) - COTAREG PM (antihypertensive - 43 M€)
Responsible for GP and/or Specialists communication
o Definition of qualitative and quantitative objectives in a very competitive market
o Management of the premarketing of a new indication
o Strategy and campaigns working out and follow up
Loyalty operations and Customer Relationship Management (Phases IV, PMS,
Professional Relationship, Mailings, …)
o Mega PR Project Manager (2 M€ budget)
o Sales Forces training
o Management of 1 Junior PM
